{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:35:48Z","timestamp":1767141348729,"version":"build-2238731810"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T00:00:00Z","timestamp":1693094400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T00:00:00Z","timestamp":1693094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100008460","name":"National Center for Complementary and Integrative Health","doi-asserted-by":"publisher","award":["No.2017042401"],"award-info":[{"award-number":["No.2017042401"]}],"id":[{"id":"10.13039\/100008460","id-type":"DOI","asserted-by":"publisher"}]},{"name":"JSPS KAKENHI Grant","award":["JP17K16773"],"award-info":[{"award-number":["JP17K16773"]}]},{"name":"JSPS KAKENHI Grant","award":["JP17H04108"],"award-info":[{"award-number":["JP17H04108"]}]},{"name":"JSPS KAKENHI Grant","award":["JP20H03580"],"award-info":[{"award-number":["JP20H03580"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s10157-023-02391-5","type":"journal-article","created":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T03:01:40Z","timestamp":1693105300000},"page":"1010-1020","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunological risk and complement genetic evaluations in early onset de novo thrombotic microangiopathy after living donor kidney transplantation: A Japanese multicenter registry"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9411-2254","authenticated-orcid":false,"given":"Nobuhiro","family":"Fujiyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Tasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Tsutahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Kamijo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko","family":"Toyoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"Iwami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Inui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Shirakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Sugimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyohiko","family":"Hotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayoshi","family":"Okumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhide","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Watarai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Hidaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuki","family":"Ohtani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norimitsu","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobutaka","family":"Wakamiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonori","family":"Habuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Japanese Post-kidney Transplant TMA Support Team","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,27]]},"reference":[{"issue":"3","key":"2391_CR1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.kint.2016.10.005","volume":"91","author":"TH Goodship","year":"2017","unstructured":"Goodship TH, Cook HT, Fakhouri F, Fervenza FC, Fremeaux-Bacchi V, Kavanagh D, et al. Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a \u201cKidney disease: improving global outcomes\u201d (KDIGO) controversies conference. Kidney Int. 2017;91(3):539\u201351. https:\/\/doi.org\/10.1016\/j.kint.2016.10.005.","journal-title":"Kidney Int"},{"issue":"1","key":"2391_CR2","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.trre.2017.10.001","volume":"32","author":"N Garg","year":"2018","unstructured":"Garg N, Rennke HG, Pavlakis M, Zandi-Nejad K. De novo thrombotic microangiopathy after kidney transplantation. Transplant Rev (Orlando). 2018;32(1):58\u201368. https:\/\/doi.org\/10.1016\/j.trre.2017.10.001.","journal-title":"Transplant Rev (Orlando)"},{"key":"2391_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8070919","author":"ML Gonzalez Suarez","year":"2019","unstructured":"Gonzalez Suarez ML, Thongprayoon C, Mao MA, Leeaphorn N, Bathini T, Cheungpasitporn W. Outcomes of kidney transplant patients with atypical hemolytic uremic syndrome treated with eculizumab: a systematic review and meta-analysis. J Clin Med. 2019. https:\/\/doi.org\/10.3390\/jcm8070919.","journal-title":"J Clin Med"},{"issue":"17","key":"2391_CR4","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1056\/NEJMra0902814","volume":"361","author":"M Noris","year":"2009","unstructured":"Noris M, Remuzzi G. Atypical hemolytic-uremic syndrome. N Engl J Med. 2009;361(17):1676\u201387. https:\/\/doi.org\/10.1056\/NEJMra0902814.","journal-title":"N Engl J Med"},{"issue":"4","key":"2391_CR5","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s10157-018-1655-2","volume":"23","author":"S Satoh","year":"2019","unstructured":"Satoh S, Saito K, Harada H, Okumi M, Saito M, Survey Committee for TATMAotJSfT. Survey of thrombotic microangiopathy within 1 week after kidney transplantation between 2010 and 2015 in Japan. Clin Exp Nephrol. 2019;23(4):571\u20132. https:\/\/doi.org\/10.1007\/s10157-018-1655-2.","journal-title":"Clin Exp Nephrol"},{"issue":"5","key":"2391_CR6","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.ajkd.2003.07.008","volume":"42","author":"JC Reynolds","year":"2003","unstructured":"Reynolds JC, Agodoa LY, Yuan CM, Abbott KC. Thrombotic microangiopathy after renal transplantation in the United States. Am J Kidney Dis. 2003;42(5):1058\u201368. https:\/\/doi.org\/10.1016\/j.ajkd.2003.07.008.","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"2391_CR7","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1111\/j.1600-6143.2008.02297.x","volume":"8","author":"M Le Quintrec","year":"2008","unstructured":"Le Quintrec M, Lionet A, Kamar N, Karras A, Barbier S, Buchler M, et al. Complement mutation-associated de novo thrombotic microangiopathy following kidney transplantation. Am J Transplant. 2008;8(8):1694\u2013701. https:\/\/doi.org\/10.1111\/j.1600-6143.2008.02297.x.","journal-title":"Am J Transplant"},{"issue":"9","key":"2391_CR8","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.2215\/cjn.06230614","volume":"10","author":"DR Mathern","year":"2015","unstructured":"Mathern DR, Heeger PS. Molecules great and small: the complement system. Clin J Am Soc Nephrol. 2015;10(9):1636\u201350. https:\/\/doi.org\/10.2215\/cjn.06230614.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2391_CR9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3389\/fmed.2017.00066","volume":"4","author":"M Cernoch","year":"2017","unstructured":"Cernoch M, Viklicky O. Complement in kidney transplantation. Front Med. 2017;4:66. https:\/\/doi.org\/10.3389\/fmed.2017.00066.","journal-title":"Front Med"},{"issue":"3","key":"2391_CR10","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.trre.2018.01.001","volume":"32","author":"M Manook","year":"2018","unstructured":"Manook M, Kwun J, Sacks S, Dorling A, Mamode N, Knechtle S. Innate networking: Thrombotic microangiopathy, the activation of coagulation and complement in the sensitized kidney transplant recipient. Transplant Rev (Orlando). 2018;32(3):119\u201326. https:\/\/doi.org\/10.1016\/j.trre.2018.01.001.","journal-title":"Transplant Rev (Orlando)"},{"issue":"11","key":"2391_CR11","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1097\/TP.0000000000000200","volume":"98","author":"D Matar","year":"2014","unstructured":"Matar D, Naqvi F, Racusen LC, Carter-Monroe N, Montgomery RA, Alachkar N. Atypical hemolytic uremic syndrome recurrence after kidney transplantation. Transplantation. 2014;98(11):1205\u201312. https:\/\/doi.org\/10.1097\/TP.0000000000000200.","journal-title":"Transplantation"},{"issue":"12","key":"2391_CR12","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/s41581-018-0071-x","volume":"14","author":"AR Biglarnia","year":"2018","unstructured":"Biglarnia AR, Huber-Lang M, Mohlin C, Ekdahl KN, Nilsson B. The multifaceted role of complement in kidney transplantation. Nat Rev Nephrol. 2018;14(12):767\u201381. https:\/\/doi.org\/10.1038\/s41581-018-0071-x.","journal-title":"Nat Rev Nephrol"},{"issue":"8","key":"2391_CR13","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1097\/TP.0b013e3181f24e8d","volume":"90","author":"BS Cho","year":"2010","unstructured":"Cho BS, Yahng SA, Lee SE, Eom KS, Kim YJ, Kim HJ, et al. Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation. Transplantation. 2010;90(8):918\u201326. https:\/\/doi.org\/10.1097\/TP.0b013e3181f24e8d.","journal-title":"Transplantation"},{"issue":"12","key":"2391_CR14","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1111\/iju.14118","volume":"26","author":"M Tasaki","year":"2019","unstructured":"Tasaki M, Saito K, Nakagawa Y, Imai N, Ito Y, Yoshida Y, et al. Analysis of the prevalence of systemic de novo thrombotic microangiopathy after ABO-incompatible kidney transplantation and the associated risk factors. Int J Urol. 2019;26(12):1128\u201337. https:\/\/doi.org\/10.1111\/iju.14118.","journal-title":"Int J Urol"},{"issue":"2","key":"2391_CR15","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s10157-007-0461-z","volume":"11","author":"K Takahashi","year":"2007","unstructured":"Takahashi K. Recent findings in ABO-incompatible kidney transplantation: classification and therapeutic strategy for acute antibody-mediated rejection due to ABO-blood-group-related antigens during the critical period preceding the establishment of accommodation. Clin Exp Nephrol. 2007;11(2):128\u201341. https:\/\/doi.org\/10.1007\/s10157-007-0461-z.","journal-title":"Clin Exp Nephrol"},{"issue":"12 Suppl","key":"2391_CR16","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1097\/01.tp.0000296018.82857.ef","volume":"84","author":"K Tanabe","year":"2007","unstructured":"Tanabe K. Interinstitutional variation in the measurement of anti-A\/B antibodies: the Japanese ABO-incompatible transplantation committee survey. Transplantation. 2007;84(12 Suppl):S13\u20136. https:\/\/doi.org\/10.1097\/01.tp.0000296018.82857.ef.","journal-title":"Transplantation"},{"issue":"3","key":"2391_CR17","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.ekir.2018.11.010","volume":"4","author":"AM Siedlecki","year":"2019","unstructured":"Siedlecki AM, Isbel N, Vande Walle J, James Eggleston J, Cohen DJ, Global a HUSR. Eculizumab use for kidney transplantation in patients with a diagnosis of atypical hemolytic uremic syndrome. Kidney Int Rep. 2019;4(3):434\u201346. https:\/\/doi.org\/10.1016\/j.ekir.2018.11.010.","journal-title":"Kidney Int Rep"},{"key":"2391_CR18","doi-asserted-by":"publisher","DOI":"10.1097\/tp.0000000000004355","author":"EK Glover","year":"2022","unstructured":"Glover EK, Smith-Jackson K, Brocklebank V, Wilson V, Walsh PR, Montgomery EK, et al. Assessing the impact of prophylactic eculizumab on renal graft survival in atypical hemolytic uremic syndrome. Transplantation. 2022. https:\/\/doi.org\/10.1097\/tp.0000000000004355.","journal-title":"Transplantation"},{"issue":"4","key":"2391_CR19","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s10157-016-1321-5","volume":"21","author":"K Takahashi","year":"2017","unstructured":"Takahashi K, Saito K, Takahara S, Fuchinoue S, Yagisawa T, Aikawa A, et al. Results of a multicenter prospective clinical study in Japan for evaluating efficacy and safety of desensitization protocol based on rituximab in ABO-incompatible kidney transplantation. Clin Exp Nephrol. 2017;21(4):705\u201313. https:\/\/doi.org\/10.1007\/s10157-016-1321-5.","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"2391_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trre.2012.07.003","volume":"27","author":"K Takahashi","year":"2013","unstructured":"Takahashi K, Saito K. ABO-incompatible kidney transplantation. Transplant Rev (Orlando). 2013;27(1):1\u20138. https:\/\/doi.org\/10.1016\/j.trre.2012.07.003.","journal-title":"Transplant Rev (Orlando)"},{"issue":"8","key":"2391_CR21","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.2215\/cjn.00540118","volume":"13","author":"AE de Weerd","year":"2018","unstructured":"de Weerd AE, Betjes MGH. ABO-incompatible kidney transplant outcomes: a meta-analysis. Clin J Am Soc Nephrol. 2018;13(8):1234\u201343. https:\/\/doi.org\/10.2215\/cjn.00540118.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"2391_CR22","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/j.1600-6143.2009.02870.x","volume":"10","author":"AM Waters","year":"2010","unstructured":"Waters AM, Pappworth I, Marchbank K, Bockenhauer D, Tullus K, Pickering MC, et al. Successful renal transplantation in factor H autoantibody associated HUS with CFHR1 and 3 deficiency and CFH variant G2850T. Am J Transplant. 2010;10(1):168\u201372. https:\/\/doi.org\/10.1111\/j.1600-6143.2009.02870.x.","journal-title":"Am J Transplant"},{"issue":"3","key":"2391_CR23","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1159\/000468528","volume":"136","author":"S Milan Manani","year":"2017","unstructured":"Milan Manani S, Virzi GM, Giuliani A, Clementi A, Brocca A, Dissegna D, et al. Hemolytic uremic syndrome and kidney transplantation: a case series and review of the literature. Nephron. 2017;136(3):245\u201353. https:\/\/doi.org\/10.1159\/000468528.","journal-title":"Nephron"},{"issue":"11","key":"2391_CR24","doi-asserted-by":"publisher","first-page":"e0188155","DOI":"10.1371\/journal.pone.0188155","volume":"12","author":"LGM de Andrade","year":"2017","unstructured":"de Andrade LGM, Contti MM, Nga HS, Bravin AM, Takase HM, Viero RM, et al. Long-term outcomes of the atypical hemolytic uremic syndrome after kidney transplantation treated with eculizumab as first choice. PLoS ONE. 2017;12(11):e0188155. https:\/\/doi.org\/10.1371\/journal.pone.0188155.","journal-title":"PLoS ONE"},{"issue":"9","key":"2391_CR25","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1111\/j.1600-6143.2012.04124.x","volume":"12","author":"D Noone","year":"2012","unstructured":"Noone D, Al-Matrafi J, Tinckam K, Zipfel PF, Herzenberg AM, Thorner PS, et al. Antibody mediated rejection associated with complement factor h-related protein 3\/1 deficiency successfully treated with eculizumab. Am J Transplant. 2012;12(9):2546\u201353. https:\/\/doi.org\/10.1111\/j.1600-6143.2012.04124.x.","journal-title":"Am J Transplant"},{"issue":"6","key":"2391_CR26","doi-asserted-by":"publisher","first-page":"E130","DOI":"10.1111\/petr.12537","volume":"19","author":"R Grenda","year":"2015","unstructured":"Grenda R, Jarmu\u017cek W, Rubik J, Prokurat S, Miklaszewska M, Drozdz D, et al. Favorable four-yr outcome after renal transplantation in a patient with complement factor H antibody and CFHR1\/CFHR3 gene mutation-associated HUS. Pediatr Transplant. 2015;19(6):E130\u20134. https:\/\/doi.org\/10.1111\/petr.12537.","journal-title":"Pediatr Transplant"},{"issue":"12","key":"2391_CR27","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1097\/TP.0000000000001909","volume":"101","author":"C Levi","year":"2017","unstructured":"Levi C, Fremeaux-Bacchi V, Zuber J, Rabant M, Devriese M, Snanoudj R, et al. Midterm outcomes of 12 renal transplant recipients treated with eculizumab to prevent atypical hemolytic syndrome recurrence. Transplantation. 2017;101(12):2924\u201330. https:\/\/doi.org\/10.1097\/TP.0000000000001909.","journal-title":"Transplantation"},{"issue":"2","key":"2391_CR28","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1182\/blood-2011-03-339903","volume":"119","author":"NJ Francis","year":"2012","unstructured":"Francis NJ, McNicholas B, Awan A, Waldron M, Reddan D, Sadlier D, et al. A novel hybrid CFH\/CFHR3 gene generated by a microhomology-mediated deletion in familial atypical hemolytic uremic syndrome. Blood. 2012;119(2):591\u2013601. https:\/\/doi.org\/10.1182\/blood-2011-03-339903.","journal-title":"Blood"},{"issue":"19","key":"2391_CR29","doi-asserted-by":"publisher","first-page":"E4433","DOI":"10.1073\/pnas.1717600115","volume":"115","author":"S Cantsilieris","year":"2018","unstructured":"Cantsilieris S, Nelson BJ, Huddleston J, Baker C, Harshman L, Penewit K, et al. Recurrent structural variation, clustered sites of selection, and disease risk for the complement factor H (CFH) gene family. Proc Natl Acad Sci USA. 2018;115(19):E4433\u201342. https:\/\/doi.org\/10.1073\/pnas.1717600115.","journal-title":"Proc Natl Acad Sci USA"}],"updated-by":[{"DOI":"10.1007\/s10157-023-02409-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T00:00:00Z","timestamp":1697846400000}}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-023-02391-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-023-02391-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-023-02391-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T05:06:44Z","timestamp":1700111204000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-023-02391-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,27]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["2391"],"URL":"https:\/\/doi.org\/10.1007\/s10157-023-02391-5","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,27]]},"assertion":[{"value":"21 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s10157-023-02409-y","URL":"https:\/\/doi.org\/10.1007\/s10157-023-02409-y","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Honoraria: Tomonori Habuchi (Astellas Pharma Co., Ono Pharmaceutical Co., Janssen Pharmaceutical Co., and Takeda Pharmaceutical Co.), Research Funding: Norimitsu Inoue (Alexion Pharma GK) and Tomonori Habuchi (Mochida Pharmaceutical Co.).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The studies involving human participants were reviewed and approved by the Akita University School of Medicine Ethics Committee (No. 2301), and the Wakayama Medical School Ethics Committee (No. 154).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}